BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28957391)

  • 1. Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
    Hossain F; Ghosh P; Khan MAA; Duthie MS; Vallur AC; Picone A; Howard RF; Reed SG; Mondal D
    PLoS One; 2017; 12(9):e0185606. PubMed ID: 28957391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL).
    Kumar A; Singh VK; Madhukar P; Tiwari R; Roy R; Rajneesh ; Mehrotra S; Sundar S; Kumar R
    Mol Biol Rep; 2024 Jun; 51(1):716. PubMed ID: 38824237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time Fluorimetry Loop-Mediated Isothermal Amplification for Diagnosis of Leishmaniasis and as a Tool for Assessment of Cure for Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Gupta R; Negi NS; Singh R; Salotra P
    Am J Trop Med Hyg; 2021 Apr; 104(6):2097-2107. PubMed ID: 33872204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients.
    Khan MAA; Faisal K; Chowdhury R; Nath R; Ghosh P; Ghosh D; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2021 Sep; 14(1):465. PubMed ID: 34503557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
    Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
    Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.
    Nasreen SA; Hossain MA; Paul SK; Mahmud MC; Ahmed S; Ghosh S; Kobayashi N
    Jpn J Infect Dis; 2012 Jul; 65(4):315-7. PubMed ID: 22814154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
    J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Verma S; Avishek K; Sharma V; Negi NS; Ramesh V; Salotra P
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):390-5. PubMed ID: 23433714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PCR procedures for detecting and quantifying Leishmania donovani DNA in large numbers of dried human blood samples from a visceral leishmaniasis focus in Northern Ethiopia.
    Abbasi I; Aramin S; Hailu A; Shiferaw W; Kassahun A; Belay S; Jaffe C; Warburg A
    BMC Infect Dis; 2013 Mar; 13():153. PubMed ID: 23530965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection.
    Verma S; Singh R; Sharma V; Bumb RA; Negi NS; Ramesh V; Salotra P
    BMC Infect Dis; 2017 Mar; 17(1):223. PubMed ID: 28335752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Upadhyay S; Singh AK; Singh OP; Sundar S; Singh R; Salotra P
    J Clin Microbiol; 2021 Aug; 59(9):e0013221. PubMed ID: 34160275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for detection of Leishmania DNA in buffy coat from visceral leishmaniasis patients.
    Khan MG; Bhaskar KR; Salam MA; Akther T; Pluschke G; Mondal D
    Parasit Vectors; 2012 Dec; 5():280. PubMed ID: 23206441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
    Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
    BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.
    Mondal D; Ghosh P; Chowdhury R; Halleux C; Ruiz-Postigo JA; Alim A; Hossain F; Khan MAA; Nath R; Duthie MS; Kroeger A; Matlashewski G; Argaw D; Olliaro P
    Front Microbiol; 2019; 10():2268. PubMed ID: 31649631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
    Bhandari V; Kulshrestha A; Deep DK; Stark O; Prajapati VK; Ramesh V; Sundar S; Schonian G; Dujardin JC; Salotra P
    PLoS Negl Trop Dis; 2012; 6(5):e1657. PubMed ID: 22629478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D; Bern C; Ghosh D; Rashid M; Molina R; Chowdhury R; Nath R; Ghosh P; Chapman LAC; Alim A; Bilbe G; Alvar J
    Clin Infect Dis; 2019 Jul; 69(2):251-258. PubMed ID: 30357373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-gal enzyme-linked immunosorbent assay for the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Datta S; Ghosh M; Sarkar S; Saha B; Mukhopadhyay S
    Indian J Dermatol Venereol Leprol; 2019; 85(6):578-589. PubMed ID: 31397399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.